Kenvue Essential Health — Segment adjusted Cost of sales increased by 0.2% to $518.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.4%, from $496.00M to $518.00M. Over 3 years (FY 2022 to FY 2025), Essential Health — Segment adjusted Cost of sales shows relatively stable performance with a -1.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Lower costs relative to sales indicate improved manufacturing efficiency or better input cost management.
The direct costs associated with producing and delivering the products sold within the Essential Health segment, excludi...
Comparable to Cost of Goods Sold (COGS) reported by peers in the consumer health industry.
kvue_segment_essential_health_segment_adjusted_cost_of_sales| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $539.25M | $539.25M | $539.25M | $539.25M | $557.00M | $557.00M | $557.00M | $557.00M | $524.00M | $534.00M | $539.00M | $505.00M | $496.00M | $531.00M | $512.00M | $517.00M | $518.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +3.3% | +0.0% | +0.0% | +0.0% | -5.9% | +1.9% | +0.9% | -6.3% | -1.8% | +7.1% | -3.6% | +1.0% | +0.2% |
| YoY Change | — | — | — | — | +3.3% | +3.3% | +3.3% | +3.3% | -5.9% | -4.1% | -3.2% | -9.3% | -5.3% | -0.6% | -5.0% | +2.4% | +4.4% |